JP2004528334A5 - - Google Patents

Download PDF

Info

Publication number
JP2004528334A5
JP2004528334A5 JP2002583393A JP2002583393A JP2004528334A5 JP 2004528334 A5 JP2004528334 A5 JP 2004528334A5 JP 2002583393 A JP2002583393 A JP 2002583393A JP 2002583393 A JP2002583393 A JP 2002583393A JP 2004528334 A5 JP2004528334 A5 JP 2004528334A5
Authority
JP
Japan
Prior art keywords
alkyl
group
moiety
methyl
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002583393A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004528334A (ja
Filing date
Publication date
Priority claimed from SE0101387A external-priority patent/SE0101387D0/xx
Application filed filed Critical
Publication of JP2004528334A publication Critical patent/JP2004528334A/ja
Publication of JP2004528334A5 publication Critical patent/JP2004528334A5/ja
Pending legal-status Critical Current

Links

JP2002583393A 2001-04-20 2002-04-18 新規な化合物 Pending JP2004528334A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0101387A SE0101387D0 (sv) 2001-04-20 2001-04-20 Novel compounds
PCT/SE2002/000769 WO2002085866A1 (en) 2001-04-20 2002-04-18 Novel compounds

Publications (2)

Publication Number Publication Date
JP2004528334A JP2004528334A (ja) 2004-09-16
JP2004528334A5 true JP2004528334A5 (enExample) 2005-12-22

Family

ID=20283822

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002583393A Pending JP2004528334A (ja) 2001-04-20 2002-04-18 新規な化合物

Country Status (25)

Country Link
US (2) US7030139B2 (enExample)
EP (1) EP1390350A1 (enExample)
JP (1) JP2004528334A (enExample)
KR (1) KR20040022421A (enExample)
CN (1) CN1250531C (enExample)
AR (1) AR035959A1 (enExample)
BG (1) BG108271A (enExample)
BR (1) BR0208907A (enExample)
CA (1) CA2444381A1 (enExample)
CZ (1) CZ20032833A3 (enExample)
EE (1) EE200300524A (enExample)
HU (1) HUP0303825A3 (enExample)
IL (1) IL158142A0 (enExample)
IS (1) IS6971A (enExample)
MX (1) MXPA03009558A (enExample)
MY (1) MY134568A (enExample)
NO (1) NO20034665L (enExample)
NZ (1) NZ528403A (enExample)
PL (1) PL366517A1 (enExample)
RU (1) RU2312864C2 (enExample)
SE (1) SE0101387D0 (enExample)
SK (1) SK13032003A3 (enExample)
UA (1) UA76743C2 (enExample)
WO (1) WO2002085866A1 (enExample)
ZA (1) ZA200307752B (enExample)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2478338A1 (en) 2002-03-08 2003-09-18 Signal Pharmaceuticals, Inc. Combination therapy for treating, preventing or managing proliferative disorders and cancers
SE0203070D0 (en) * 2002-10-16 2002-10-16 Astrazeneca Ab Novel compounds
KR20050122210A (ko) * 2003-03-17 2005-12-28 다케다 샌디에고, 인코포레이티드 히스톤 탈아세틸화 효소 억제제
SE0300908D0 (sv) * 2003-03-31 2003-03-31 Astrazeneca Ab Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
SE0301446D0 (sv) 2003-05-16 2003-05-16 Astrazeneca Ab New Compounds
SE0301699D0 (sv) 2003-06-10 2003-06-10 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0301701D0 (sv) * 2003-06-10 2003-06-10 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0301698D0 (sv) * 2003-06-10 2003-06-10 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
US7465815B2 (en) * 2003-06-26 2008-12-16 Takeda Pharmaceutical Company Limited Cannabinoid receptor modulator
US7157471B2 (en) * 2003-08-25 2007-01-02 Boehringer Ingelheim International Gmbh Haloalkyl- and piperidine-substituted benzimidazole-derivatives
WO2005021547A2 (en) * 2003-08-28 2005-03-10 Pharmaxis Pty Ltd. Heterocyclic cannabinoid cb2 receptor antagonists
SE0302571D0 (sv) * 2003-09-26 2003-09-26 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302573D0 (sv) * 2003-09-26 2003-09-26 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302570D0 (sv) * 2003-09-26 2003-09-26 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302572D0 (sv) * 2003-09-26 2003-09-26 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
WO2005037798A2 (en) * 2003-10-16 2005-04-28 Cara Therapeutics, Inc Amide or thiomide derivatives and their use in the treatment of pain
WO2006033631A1 (en) * 2004-09-24 2006-03-30 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i
MX2007003105A (es) * 2004-09-24 2007-06-07 Aztrazeneca Ab Derivados de bencimidazol, composiciones que los contienen, sus preparaciones y sus usos i.
EP1797074A4 (en) * 2004-09-24 2009-04-01 Astrazeneca Ab COMPOUNDS, COMPOSITIONS CONTAINING THEM, PREPARATION THEREOF AND APPLICATIONS THEREOF IIII
WO2006033633A1 (en) * 2004-09-24 2006-03-30 Astrazeneca Ab Compounds, compositions containing them, preparations thereof and uses thereof ii
UA87327C2 (ru) * 2004-09-24 2009-07-10 Астразенека Аб Производные бензимидазола, композиция, которая их содержит, их получение и применение
WO2006033630A1 (en) * 2004-09-24 2006-03-30 Astrazeneca Ab Compounds, compositions containing them, preparation thereof and uses thereof iii
EP1797075A1 (en) * 2004-09-24 2007-06-20 AstraZeneca AB Benzimidazole derivatives and their use as cannabinoid receptor ligands
JP2008514594A (ja) * 2004-09-24 2008-05-08 アストラゼネカ・アクチエボラーグ ベンゾイミダゾール誘導体及びカンナビノイド受容体リガンドとしてのその使用ｉ
WO2006033628A1 (en) * 2004-09-24 2006-03-30 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
AU2005298986A1 (en) 2004-10-27 2006-05-04 F. Hoffmann-La Roche Ag New indole or benzimidazole derivatives
EP1809607B1 (en) * 2004-11-02 2008-12-17 Pfizer, Inc. Sulfonyl benzimidazole derivatives
SE0402762D0 (sv) * 2004-11-11 2004-11-11 Astrazeneca Ab Indazole sulphonamide derivatives
SE0402763D0 (sv) * 2004-11-11 2004-11-11 Astrazeneca Ab Nitro indazole derivatives
DE602006019213D1 (de) 2005-03-15 2011-02-10 Pfizer Benzimidazolonderivate als cb2-rezeptor-liganden
WO2006116399A2 (en) 2005-04-28 2006-11-02 Ferring B.V. Use of novel compounds for ibd treatment
UY30048A1 (es) 2005-12-23 2007-07-31 Astrazeneca Ab Derivados sustituidos de la n,2-(1h-benzimidazol-1-il) acetamida, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones
WO2007091950A1 (en) * 2006-02-07 2007-08-16 Astrazeneca Ab Benzimidazoles and imidazopyridines useful in the treatment of diseases or disorders associated with cannabinoid receptor 2 (cb2) such as pain
JP2009536918A (ja) * 2006-03-06 2009-10-22 ファイザー株式会社 スルホニルベンゾイミダゾール誘導体
TW200745049A (en) * 2006-03-23 2007-12-16 Astrazeneca Ab New crystalline forms
TW200808769A (en) * 2006-04-18 2008-02-16 Astrazeneca Ab Therapeutic compounds
TW200808772A (en) * 2006-06-13 2008-02-16 Astrazeneca Ab Therapeutic compounds
EA200970080A1 (ru) * 2006-07-04 2009-06-30 Янссен Фармацевтика Нв Бензимидазольные агонисты каннабиноидов, содержащие замещенную гетероциклическую группу
TWI433839B (zh) 2006-08-11 2014-04-11 Neomed Inst 新穎的苯并咪唑衍生物290
FR2907784B1 (fr) * 2006-10-27 2009-02-13 Sod Conseils Rech Applic Derives phenyliques et leur utilisation comme medicament
WO2009116074A2 (en) * 2008-02-13 2009-09-24 Cadila Healthcare Limited Substituted benzimidazoles as cannabinoid modulator
WO2011009883A1 (en) 2009-07-23 2011-01-27 INSERM (Institut National de la Santé et de la Recherche Médicale) Selective cb2 receptor agonists for use in the prevention or treatment of alcoholic liver disease
US20110086853A1 (en) * 2009-10-08 2011-04-14 William Brown Therapeutic Compounds
ES2679918T3 (es) 2010-02-18 2018-08-31 Vtv Therapeutics Llc Derivados de imidazol condensados sustituidos, composiciones farmacéuticas y métodos de uso de los mismos
US8759535B2 (en) 2010-02-18 2014-06-24 High Point Pharmaceuticals, Llc Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
JP6162694B2 (ja) 2011-07-18 2017-07-12 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ ベンズアミド類
CN102977056B (zh) * 2012-11-28 2014-11-26 深圳万乐药业有限公司 N-苄氧羰基-3-氟-4-吗啉基苯胺的合成方法
WO2016089648A1 (en) 2014-12-01 2016-06-09 Vtv Therapeutics Llc Bach 1 inhibitors in combination with nrf2 activators and pharmaceutical compositions thereof
WO2017157332A1 (zh) * 2016-03-18 2017-09-21 江苏恒瑞医药股份有限公司 芳香酰胺类衍生物、其制备方法及其在医药上的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2945044A (en) * 1957-07-12 1960-07-12 Ciba Pharm Prod Inc Certain 1-(diethyl-aminoethyl), 5-amino, 2-benzyl or substituted benzyl, benzimidazoles
FR1481049A (fr) 1965-11-25 1967-05-19 France Ministre Des Armees Nouveaux dialkylaminoalkyl-1 p-alkoxyphényl alkyl-2 benzimidazoles 5-substitués
JPH09510695A (ja) * 1994-01-03 1997-10-28 エイシア・ファーマシュウティカルズ，インコーポレイテッド ８−アザ、６−アザ、および６，８−ジアザ−１，４−ジヒドロキノキサリン−２，３−ジオン類およびそのグリシン／ｎｍｄａリセプターに対するアンタゴニストとしての使用
CA2192206A1 (en) * 1994-06-10 1995-12-21 Bernhard Kohl Thiopyridines for use in the control of helicobacter bacteria
SE0203070D0 (en) * 2002-10-16 2002-10-16 Astrazeneca Ab Novel compounds

Similar Documents

Publication Publication Date Title
RU2003129638A (ru) Новые соединения
AU2019283921B2 (en) Indole carboxamide compounds useful as kinase inhibitors
JP2024521979A5 (enExample)
JP2019517487A5 (enExample)
TWI579284B (zh) 咪唑并吡咯啶酮化合物
RU2388750C2 (ru) Ингибиторы фосфодиэстеразы 4, включая аналоги n-замещенного диариламина
JP2005535586A5 (enExample)
US9737522B2 (en) NMDA receptor modulators and uses related thereto
JP2009526830A5 (enExample)
JP2006143737A5 (enExample)
JP2006513265A5 (enExample)
JP2010530431A5 (enExample)
JP2017533968A5 (enExample)
JP2008513498A5 (enExample)
JP2004518723A5 (enExample)
WO2005077950A3 (en) Medicaments with hm74a receptor activity
JP2011524422A5 (enExample)
JP2005501120A5 (enExample)
CA2568608A1 (en) Six membered amino-amide derivatives as angiogenesis inhibitors
JP2006524222A5 (enExample)
AU2015335783B2 (en) Tricyclic atropisomer compounds
RU2005114021A (ru) Производные имидазола и их применение в качестве периферически-селективных ингибиторов дофамин-бета-гидролазы
CA2564442A1 (en) 2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors
EP3675858B1 (en) Imidazo[1,5-a]pyrazine compounds and compositions for ire1 inhibition
JP2005526024A5 (enExample)